Published in Emerg Infect Dis on October 01, 2002
Identification of anthrax toxin genes in a Bacillus cereus associated with an illness resembling inhalation anthrax. Proc Natl Acad Sci U S A (2004) 4.73
Characterization of Bacillus cereus isolates associated with fatal pneumonias: strains are closely related to Bacillus anthracis and harbor B. anthracis virulence genes. J Clin Microbiol (2006) 3.15
Pathology and pathogenesis of bioterrorism-related inhalational anthrax. Am J Pathol (2003) 2.11
Detecting bioterror attacks by screening blood donors: a best-case analysis. Emerg Infect Dis (2003) 1.57
Detection of anthrax toxin in the serum of animals infected with Bacillus anthracis by using engineered immunoassays. Clin Vaccine Immunol (2006) 1.50
Public health in the time of bioterrorism. Emerg Infect Dis (2002) 1.46
The critical role of pathology in the investigation of bioterrorism-related cutaneous anthrax. Am J Pathol (2003) 1.17
Association of Bacillus anthracis capsule with lethal toxin during experimental infection. Infect Immun (2008) 1.08
Capsule production in Bacillus cereus strains associated with severe pneumonia. J Clin Microbiol (2006) 1.02
Treatment of experimental anthrax with recombinant capsule depolymerase. Antimicrob Agents Chemother (2007) 1.02
Nonhemolytic, nonmotile gram-positive rods indicative of Bacillus anthracis. Emerg Infect Dis (2003) 0.94
Label-free flow-enhanced specific detection of Bacillus anthracis using a piezoelectric microcantilever sensor. Analyst (2008) 0.87
Structural and immunochemical relatedness suggests a conserved pathogenicity motif for secondary cell wall polysaccharides in Bacillus anthracis and infection-associated Bacillus cereus. PLoS One (2017) 0.75
Multiple-locus variable-number tandem repeat analysis reveals genetic relationships within Bacillus anthracis. J Bacteriol (2000) 15.34
Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis (2001) 11.73
Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis--one species on the basis of genetic evidence. Appl Environ Microbiol (2000) 7.87
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.06
Biological warfare. A historical perspective. JAMA (1997) 4.10
Public-health preparedness for biological terrorism in the USA. Lancet (2000) 3.43
Fatal inhalational anthrax in a 94-year-old Connecticut woman. JAMA (2002) 3.26
Fatal inhalational anthrax with unknown source of exposure in a 61-year-old woman in New York City. JAMA (2002) 2.46
Anthrax as a potential biological warfare agent. Arch Intern Med (1998) 2.40
Evaluation and validation of a real-time polymerase chain reaction assay for rapid identification of Bacillus anthracis. Emerg Infect Dis (2002) 2.23
Bioterrorism: implications for the clinical microbiologist. Clin Microbiol Rev (2001) 2.19
Characterization of the Bacillus anthracis S-layer: cloning and sequencing of the structural gene. J Bacteriol (1995) 2.01
Identification of Bacillus anthracis by using monoclonal antibody to cell wall galactose-N-acetylglucosamine polysaccharide. J Clin Microbiol (1990) 1.48
The capsule of bacillus anthracis, a review J Appl Microbiol (1999) 1.44
Immunological analysis of cell-associated antigens of Bacillus anthracis. Infect Immun (1988) 1.30
Identification of Bacillus anthracis by polyclonal antibodies against extracted vegetative cell antigens. J Appl Bacteriol (1989) 1.01
Bacillus anthracis surface: capsule and S-layer. J Appl Microbiol (1999) 0.98
APPLICATION OF FLUORESCENT ANTIBODIES FOR DEMONSTRATING B. ANTHRACIS IN THE ORGANS OF INFECTED ANIMALS. J Hyg Epidemiol Microbiol Immunol (1964) 0.84
Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis (2002) 5.23
Identification of anthrax toxin genes in a Bacillus cereus associated with an illness resembling inhalation anthrax. Proc Natl Acad Sci U S A (2004) 4.73
Characterization of encapsulated and noncapsulated Haemophilus influenzae and determination of phylogenetic relationships by multilocus sequence typing. J Clin Microbiol (2003) 4.47
Fatal inhalational anthrax in a 94-year-old Connecticut woman. JAMA (2002) 3.26
Characterization of Bacillus cereus isolates associated with fatal pneumonias: strains are closely related to Bacillus anthracis and harbor B. anthracis virulence genes. J Clin Microbiol (2006) 3.15
Evaluation of four commercially available rapid serologic tests for diagnosis of leptospirosis. J Clin Microbiol (2003) 3.01
Molecular subtyping of Bacillus anthracis and the 2001 bioterrorism-associated anthrax outbreak, United States. Emerg Infect Dis (2002) 2.99
Phylogeographic reconstruction of a bacterial species with high levels of lateral gene transfer. BMC Biol (2009) 2.94
Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex. J Infect Dis (2002) 2.88
Investigations of 2 cases of diphtheria-like illness due to toxigenic Corynebacterium ulcerans. Clin Infect Dis (2008) 2.73
Sequencing of 16S rRNA gene: a rapid tool for identification of Bacillus anthracis. Emerg Infect Dis (2002) 2.54
Detection of pathogenic Leptospira spp. through TaqMan polymerase chain reaction targeting the LipL32 gene. Diagn Microbiol Infect Dis (2009) 2.41
Leptospirosis in "Eco-Challenge" athletes, Malaysian Borneo, 2000. Emerg Infect Dis (2003) 2.35
Evaluation and validation of a real-time polymerase chain reaction assay for rapid identification of Bacillus anthracis. Emerg Infect Dis (2002) 2.23
Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis. J Clin Microbiol (2004) 2.20
Tetanus immunity and physician compliance with tetanus prophylaxis practices among emergency department patients presenting with wounds. Ann Emerg Med (2004) 2.17
Use of 16S rRNA gene sequencing for rapid identification and differentiation of Burkholderia pseudomallei and B. mallei. J Clin Microbiol (2003) 2.15
Pathology and pathogenesis of bioterrorism-related inhalational anthrax. Am J Pathol (2003) 2.11
Surface sampling methods for Bacillus anthracis spore contamination. Emerg Infect Dis (2002) 2.11
Outbreak of leptospirosis among triathlon participants and community residents in Springfield, Illinois, 1998. Clin Infect Dis (2002) 2.02
Use of 16S rRNA gene sequencing for rapid confirmatory identification of Brucella isolates. J Clin Microbiol (2004) 1.97
The scientific basis for law as a public health tool. Am J Public Health (2008) 1.91
Antimicrobial susceptibility testing of Bacillus anthracis: comparison of results obtained by using the National Committee for Clinical Laboratory Standards broth microdilution reference and Etest agar gradient diffusion methods. J Clin Microbiol (2002) 1.83
Species-specific identification of Leptospiraceae by 16S rRNA gene sequencing. J Clin Microbiol (2006) 1.80
Mutator clones of Neisseria meningitidis in epidemic serogroup A disease. Proc Natl Acad Sci U S A (2002) 1.77
Utility of composite reference standards and latent class analysis in evaluating the clinical accuracy of diagnostic tests for pertussis. Clin Vaccine Immunol (2007) 1.70
Diagnostic accuracy of real-time PCR assays targeting 16S rRNA and lipL32 genes for human leptospirosis in Thailand: a case-control study. PLoS One (2011) 1.70
Pathology and pathogenesis of fatal Bordetella pertussis infection in infants. Clin Infect Dis (2008) 1.68
Bordetella holmesii bacteremia: a newly recognized clinical entity among asplenic patients. Clin Infect Dis (2004) 1.67
Pre-Columbian origins for North American anthrax. PLoS One (2009) 1.63
Changes in predominance and diversity of genomic subtypes of Bordetella pertussis isolated in the United States, 1935 to 1999. Emerg Infect Dis (2002) 1.58
Bacillus anthracis aerosolization associated with a contaminated mail sorting machine. Emerg Infect Dis (2002) 1.52
Identification of Haemophilus influenzae serotypes by standard slide agglutination serotyping and PCR-based capsule typing. J Clin Microbiol (2003) 1.50
Significant gene order and expression differences in Bordetella pertussis despite limited gene content variation. J Bacteriol (2006) 1.48
Assessing the risk of laboratory-acquired meningococcal disease. J Clin Microbiol (2005) 1.47
Public health in the time of bioterrorism. Emerg Infect Dis (2002) 1.46
Sequence diversity of Neisseria meningitidis 16S rRNA genes and use of 16S rRNA gene sequencing as a molecular subtyping tool. J Clin Microbiol (2002) 1.45
Prevalence and sequence variants of IS481 in Bordetella bronchiseptica: implications for IS481-based detection of Bordetella pertussis. J Clin Microbiol (2006) 1.41
Issues associated with and recommendations for using PCR to detect outbreaks of pertussis. J Clin Microbiol (2002) 1.37
First case of bioterrorism-related inhalational anthrax in the United States, Palm Beach County, Florida, 2001. Emerg Infect Dis (2002) 1.34
Molecular epidemiology of anthrax cases associated with recreational use of animal hides and yarn in the United States. PLoS One (2011) 1.32
Preliminary evaluation of the API 20NE and RapID NF plus systems for rapid identification of Burkholderia pseudomallei and B. mallei. J Clin Microbiol (2005) 1.31
Effects of long-term storage on plasmid stability in Bacillus anthracis. Appl Environ Microbiol (2005) 1.30
Identification of an unusual Brucella strain (BO2) from a lung biopsy in a 52 year-old patient with chronic destructive pneumonia. BMC Microbiol (2010) 1.29
Paracoccus yeeii sp. nov. (formerly CDC group EO-2), a novel bacterial species associated with human infection. J Clin Microbiol (2003) 1.29
Kinetics of lethal factor and poly-D-glutamic acid antigenemia during inhalation anthrax in rhesus macaques. Infect Immun (2009) 1.29
Characterization of novel Brucella strains originating from wild native rodent species in North Queensland, Australia. Appl Environ Microbiol (2010) 1.28
Outbreak of tuberculosis among homeless persons coinfected with human immunodeficiency virus. Clin Infect Dis (2003) 1.26
Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51. Vaccine (2004) 1.23
Development of a real-time fluorescence PCR assay for rapid detection of the diphtheria toxin gene. J Clin Microbiol (2002) 1.22
Development and evaluation of dual-target real-time polymerase chain reaction assays to detect Bordetella spp. Diagn Microbiol Infect Dis (2008) 1.22
Comparison of two multiple-locus variable-number tandem-repeat analysis methods for molecular strain typing of human Brucella melitensis isolates from the Middle East. J Clin Microbiol (2009) 1.19
A single multilocus sequence typing (MLST) scheme for seven pathogenic Leptospira species. PLoS Negl Trop Dis (2013) 1.17
Purified Bacillus anthracis lethal toxin complex formed in vitro and during infection exhibits functional and biological activity. J Biol Chem (2005) 1.17
Genetic diversity of clinical isolates of Bacillus cereus using multilocus sequence typing. BMC Microbiol (2008) 1.17
The critical role of pathology in the investigation of bioterrorism-related cutaneous anthrax. Am J Pathol (2003) 1.17
Characterization of a Bacillus anthracis isolate causing a rare case of fatal anthrax in a 2-year-old boy from Hong Kong. J Clin Microbiol (2005) 1.16
Genotype-specific carriage of Neisseria meningitidis in Georgia counties with hyper- and hyposporadic rates of meningococcal disease. J Infect Dis (2002) 1.16
High level of sequence diversity in the 16S rRNA genes of Haemophilus influenzae isolates is useful for molecular subtyping. J Clin Microbiol (2005) 1.16
Melioidosis diagnostic workshop, 2013. Emerg Infect Dis (2015) 1.16
Anthrax outbreaks in Bangladesh, 2009-2010. Am J Trop Med Hyg (2012) 1.15
Burkholderia pseudomallei type G in Western Hemisphere. Emerg Infect Dis (2014) 1.13
Predictors of immunity after a major serogroup W-135 meningococcal disease epidemic, Burkina Faso, 2002. J Infect Dis (2006) 1.11
Transmission network analysis to complement routine tuberculosis contact investigations. Am J Public Health (2006) 1.11
Molecular approaches to identify and differentiate Bacillus anthracis from phenotypically similar Bacillus species isolates. BMC Microbiol (2006) 1.09
Lethal factor toxemia and anti-protective antigen antibody activity in naturally acquired cutaneous anthrax. J Infect Dis (2011) 1.08
Secondary cell wall polysaccharides from Bacillus cereus strains G9241, 03BB87 and 03BB102 causing fatal pneumonia share similar glycosyl structures with the polysaccharides from Bacillus anthracis. Glycobiology (2011) 1.07
Pathogenesis and diagnosis of human meningococcal disease using immunohistochemical and PCR assays. Am J Clin Pathol (2004) 1.04
Tuberculosis genotyping in six low-incidence States, 2000-2003. Am J Prev Med (2007) 1.03
Capsule production in Bacillus cereus strains associated with severe pneumonia. J Clin Microbiol (2006) 1.02
Bioterrorism-related inhalational anthrax in an elderly woman, Connecticut, 2001. Emerg Infect Dis (2003) 1.02
Texas isolates closely related to Bacillus anthracis Ames. Emerg Infect Dis (2008) 1.01